Effect of δ-opioid receptor agonist deltorphin on circulating concentrations of luteinizing hormone and follicle stimulating hormone in healthy fertile women

Human Reproduction

Volumn 13, Issue 5, 1998, Pages 1159-1162

  Bondanelli, Marta ^a   Ambrosio, Maria Rosaria ^a   Franceschetti, Paola ^a   Guerrini, Remo ^a   Valentini, Alberto ^a   Degli Uberti, Ettore Ciro ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

Deltorphin; Gonadotrophin; Women; opioid receptors

Indexed keywords

DELTA OPIATE RECEPTOR; DELTORPHIN; FOLLITROPIN; LUTEINIZING HORMONE; NALOXONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG INFUSION; FEMALE; FOLLITROPIN RELEASE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; LUTEAL PHASE; LUTEINIZING HORMONE BLOOD LEVEL; LUTEINIZING HORMONE RELEASE; MENSTRUAL CYCLE; NORMAL HUMAN;

ANIMALIA;

EID: 0031838791     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/13.5.1159     Document Type: Article

References (21)

1. Conte, D., Nordio, M., Fillo, S. et al. (1996) Aspirin inhibition of naloxoneinduced luteinizing hormone secretion in man. J. Clin. Endocrinol. Metab., 81, 1772-1775.
2. Delitala, G., Grossman, A. and Besser, M. (1983) Differential effects of opiate peptides and alkaloids on anterior pituitary hormone secretion. Neuroendocrinology, 37, 275-279.
3. Genazzani, A.R. and Petraglia, F. (1989) Opioid control of luteinizing hormone secretion in humans. J. Steroid Biochem., 33, 751-755.
4. Gerozissis, K., Dragatsis, I. and Zioudrou, C. (1993). The delta-opioid signal transduction on the gonadotropin-releasing hormone release is eicosanoid dependent. Brain Res., 626, 219-224.
5. Kalra, S.P. (1993) Mandatory neuropeptide-steroid signaling for the preovulatory luteinizing hormone-releasing hormone discharge. Endocr. Rev., 14, 507-538.
6. Kreil, G., Barra, D. Simmaco. M. et al. (1989) Deltorphin, a novel amphibian skin peptide with high selectivity and affinity for delta opioid receptors. Eur. J. Pharmacol., 162, 123-128.
7. Lazarus, L.H., Wilson, W.E., de Castiglione, R. and Guglietta, A. (1989) Dermorphin gene sequence peptide with high affinity and selectivity for delta opioid receptors. J. Biol. Chem., 264, 3047-3050.
8. Leadem, C.A. and Yagenova, S.V. (1987) Effects of specific activation of mu-, delta- and kappa-opioid receptors on the secretion of luteinizing hormone and prolactin in the ovariectomized rat. Neuroendocrinology, 45, 109-117.
9. Maggi, R., Pimpinelli, F., Martini, L. and Piva, F. (1995a) Characterization of functional opioid delta receptors in a luteinizing hormone-releasing hormone-producing neuronal cell line. Endocrinology, 136, 289-295.
10. Maggi, R., Pimpinelli, F., Martini, L. and Piva, F. (1995b) Inhibition of luteinizing hormone-releasing hormone secretion by delta-opioid agonists in GT1-1 neuronal cells. Endocrinology, 136, 5177-5181.
11. Petraglia, F., degli Uberti, E.C., Trasforini, G. et al. (1985) Dermorphin decreases plasma LH levels in human: evidence for a modulatory role of gonadal steroids. Peptides, 6, 869-872.
12. Petraglia, F., Porro, C., Facchinetti, F. et al. (1986) Opioid control of LH secretion in humans: menstrual cycle, menopause and aging reduce effect of naloxone but not morphine. Life Sci., 38, 2103-2110.
13. Pfeiffer, D.G., Pfeiffer, A., Shimohigashi, Y. et al. (1983) Predominant involvement of mu- rather than delta- or kappa-opiate receptors in LH secretion. Peptides, 4, 647-649.
14. Quigley, M.E. and Yen, S.S.C. (1980) The role of endogenous opiates in LH secretion during the menstrual cycle. J. Clin. Endocrinol. Metab., 51, 179-181.
15. Rasmussen, D.D., Gambacciani, M., Swartz, W. et al. (1989) Pulsatile gonadotropin-releasing hormone release from the human mediobasal hypothalamus in vitro: opiate receptor-mediated suppression. Neuroendocrinology, 49, 150-156.
16. Ropert, J.F., Quigley, M.E. and Yen, S.S.C. (1981) Endogenous opiates modulate pulsatile luteinizing hormone release in humans. J. Clin. Endocrinol. Metab., 52, 583-585.
17. Snowden, E.U., Dawood, F.S.K. and Dawood, M.Y. (1984) The effect of naloxone on endogenous opioid regulation of pituitary gonadotropins and prolactin during the menstrual cycle. J. Clin, Endocrinol. Metab., 59, 298-302.
18. Temussi, P.A., Picone, D., Tancredi, T. et al. (1989) Conformational properties of deltorphin: new features of the delta opioid receptors. FEBS Lett., 247, 283-288.
19. Walsh, J.P. and Clarke, I.J. (1996) Effects of central administration of highly selective opioid mu-, delta- and kappa-receptor agonists on plasma luteinizing hormone (LH), prolactin, and the estrogen-induced LH surge in ovariectomized ewes. Endocrinology, 137, 3640-3648.
20. Weisner, J.B., Koenig, J.I., Krulich, L. and Moss, R.L. (1985) Possible delta receptor mediation of the effect of beta-endorphin on luteinizing hormone (LH) release, but not on prolactin (PRL) release, in the ovariectomized rat. Endocrinology, 116, 475-477.
21. Yen, S.S.C. (1991) Hypothalamic gonadotrophin-releasing hormone: basic and clinical aspects. In Motta, M. (ed.), Brain Endocrinology. Raven Press, Ltd, New York, p. 245.